{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T10:35:38Z","timestamp":1772706938150,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":4116,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1093\/annonc\/mdn179","type":"journal-article","created":{"date-parts":[[2008,5,4]],"date-time":"2008-05-04T04:47:22Z","timestamp":1209876442000},"page":"1644-1649","source":"Crossref","is-referenced-by-count":27,"title":["Use of palifermin for the prevention of high-dose methotrexate-induced oral mucositis"],"prefix":"10.1016","volume":"19","author":[{"given":"E.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.H.","family":"Thoennissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rudat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bieker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Schliemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.","family":"Mesters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Z\u00fchlsdorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"M\u00fcller-Tidow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.E.","family":"Berdel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdn179_bb0010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1368-8375(97)00053-5","article-title":"Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity","volume":"34","author":"Sonis","year":"1998","journal-title":"Oral Oncol"},{"key":"10.1093\/annonc\/mdn179_bb0015","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrc1318","article-title":"The pathobiology of mucositis","volume":"4","author":"Sonis","year":"2004","journal-title":"Nat Rev Cancer"},{"issue":"9 Suppl","key":"10.1093\/annonc\/mdn179_bb0020","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/cncr.20162","article-title":"Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients","volume":"100","author":"Sonis","year":"2004","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdn179_bb0025","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/154411130201300502","article-title":"The biological role of nuclear factor\u2014kappaB in disease and its potential involvement in mucosal injury associated with antineoplastic therapy","volume":"13","author":"Sonis","year":"2002","journal-title":"Crit Rev Oral Biol Med"},{"key":"10.1093\/annonc\/mdn179_bb0030","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1601-0825.2006.01258.x","article-title":"Oral mucositis","volume":"12","author":"Scully","year":"2006","journal-title":"Oral Dis"},{"key":"10.1093\/annonc\/mdn179_bb0035","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1002\/(SICI)1097-0142(19980601)82:11<2275::AID-CNCR25>3.0.CO;2-Q","article-title":"The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies","volume":"82","author":"Ruescher","year":"1998","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdn179_bb0040","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S1473-3099(04)01003-5","article-title":"Mucosa or skin as source of coagulase-negative staphylococcal bacteraemia?","volume":"4","author":"Costa","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1093\/annonc\/mdn179_bb0045","first-page":"56a","article-title":"Mucositis is associated with increased rate of documented infections and treatment related mortality after high-dose therapy and autologous peripheral stem-cell transplantation","volume":"19","author":"Sezer","year":"2000","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1093\/annonc\/mdn179_bb0050","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1200\/JCO.2001.19.8.2201","article-title":"Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation","volume":"19","author":"Sonis","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdn179_bb0055","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.bbmt.2007.03.004","article-title":"Economic impact of palifermin on the costs of hospitalization for autologous hematopoetic stem-cell transplant: analysis of phase 3 trial results","volume":"13","author":"Elting","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1093\/annonc\/mdn179_bb0060","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2141.2006.06323.x","article-title":"Severe mucositis is associated with reduced survival after autologous stem cell transplantation for lymphoid malignancies","volume":"135","author":"Fanning","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1093\/annonc\/mdn179_bb0065","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/cncr.22484","article-title":"Updated clinical practice guidelines for the prevention and treatment of mucositis","volume":"109","author":"Keefe","year":"2007","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdn179_bb0070","first-page":"492","article-title":"Prevention of high-dose L-PAM-induced mucositis by cryotherapy","volume":"14","author":"Dumontet","year":"1994","journal-title":"Bone Marrow Transplant"},{"key":"10.1093\/annonc\/mdn179_bb0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1023\/A:1006026928733","article-title":"Phase I trial of edatrexate plus carboplatin in advanced solid tumors: amelioration of dose-limiting mucositis by ice chip cryotherapy","volume":"16","author":"Edelman","year":"1998","journal-title":"Invest New Drugs"},{"key":"10.1093\/annonc\/mdn179_bb0080","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0140-6736(86)92850-3","article-title":"Topical PGE2 enhances healing of chemotherapy-associated mucosal lesions","volume":"1","author":"Kuhrer","year":"1986","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1093\/annonc\/mdn179_bb0085","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1046\/j.1365-2184.35.s1.8.x","article-title":"The effects of keratinocyte growth factor in preclinical models of mucositis","volume":"35","author":"Farrell","year":"2002","journal-title":"Cell Prolif"},{"issue":"25","key":"10.1093\/annonc\/mdn179_bb0090","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1056\/NEJMoa040125","article-title":"Palifermin for oral mucositis after intensive therapy for hematologic cancers","volume":"351","author":"Spielberger","year":"2004","journal-title":"N Eng J Med"},{"key":"10.1093\/annonc\/mdn179_bb0095","first-page":"1001","article-title":"Influence of keratinocyte growth factor on clonal growth of epithelial tumor cells, lymphoma and leukemia cells and on sensitivity of tumor cells towards 5-flourouracil in vitro","volume":"25","author":"Oelmann","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1093\/annonc\/mdn179_bb0100","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1182\/blood.V94.2.825","article-title":"Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease","volume":"94","author":"Krijanovski","year":"1999","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn179_bb0105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1023\/B:JOCI.0000019785.35850.a5","article-title":"Effect of recombinant human keratinocyte growth factor (rHuKGF) on the immunopathogenesis of intestinal graft-vs.-host disease induced without preconditioning regimen","volume":"24","author":"Ellison","year":"2004","journal-title":"J Clin Immunol"},{"key":"10.1093\/annonc\/mdn179_bb0110","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/annonc\/mdl332","article-title":"Palifermin (recombinant keratinocyte growth factor-1): a pleiotropic growth factor with multiple biological activities in preventing chemotherapy- and radiotherapy-induced mucositis","volume":"18","author":"Blijlevens","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdn179_bb0115","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1128\/MCB.22.15.5492-5505.2002","article-title":"Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound","volume":"22","author":"Braun","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1093\/annonc\/mdn179_bb0120","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdn179_bb0125","first-page":"102","article-title":"Short intensive chemotherapy with rituximab seems successful in Burkitt NHL, mature B-ALL and other high grade B-NHL","author":"Hoelzer","year":"2003","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn179_bb0130","first-page":"98","article-title":"A 4-hour i.v. infusion of methotrexate 5 g\/sqm is not as efficacious for treatment of advanced B-cell neoplasms of childhood and adolescence than 24 hour i.v. infusion although less toxic. Interim results of trial NHL-BFM 95","author":"Reiter","year":"2001","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn179_bb0135","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1182\/blood.V87.2.495.bloodjournal872495","article-title":"Improved outcome in adult B-cell lymphoblastic leukemia","volume":"87","author":"H\u00f6lzer","year":"1996","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdn179_bb0140","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1200\/JCO.2005.04.1152","article-title":"Palifermin reduces the incidence of oral mucositis in patients with metastatic colorectal cancer treated with fluorouracil-based chemotherapy","volume":"24","author":"Rosen","year":"2006","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1093\/annonc\/mdn179_bb0145","article-title":"Interventions for preventing oral mucositis for patients with cancer receiving treatment","author":"Worthington","year":"2007","journal-title":"The Cochrane Library"},{"issue":"24","key":"10.1093\/annonc\/mdn179_bb0150","doi-asserted-by":"crossref","first-page":"8318","DOI":"10.1158\/1078-0432.CCR-04-1118","article-title":"Phase I\/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous stem cell transplantation","volume":"10","author":"Freytes","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1093\/annonc\/mdn179_bb0155","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1200\/JCO.2003.10.079","article-title":"Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: potential role as mucosal protectant","volume":"21","author":"Merepol","year":"2003","journal-title":"J Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419402159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419402159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/19\/9\/1644\/546568\/mdn179.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T08:40:26Z","timestamp":1624437626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419402159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0923753419402159"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdn179","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}